Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression

por Bennani, N Nora, Kim, Hyo Jin, Pederson, Levi D, Atherton, Pamela J, Micallef, Ivana N, Thanarajasingam, Gita, Nowakowski, Grzegorz S, Witzig, Thomas, Feldman, Andrew L, Ansell, Stephen M
Publicado 2022

Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis

por Torka, Pallawi, Pederson, Levi D., Knopp, Michael V., Poon, David, Zhang, Jun, Kahl, Brad S., Higley, Howard R., Kelloff, Gary, Friedberg, Jonathan W., Schwartz, Lawrence H., Wilson, Wyndham H., Leonard, John P., Bartlett, Nancy L., Schöder, Heiko, Ruppert, Amy S.
Publicado 2023